Literature DB >> 17129519

[Virus and systemic vasculitis].

B Cervantes Bonet1, J L Callejas Rubio, N Ortego Centeno.   

Abstract

The participation of genetic and environmental factors has always been invoked in the pathogenesis of the autoimmune systemic diseases, including the primary vasculitides. Among the environmental factors, infections, fundamentally those having a viral nature, have always been focused on, especially after the discovery of the close existing relationship between the polyarteritis nodosa and the hepatitis B virus, on the one hand, and mixed cryoglobulinemia and the hepatitis C virus, on the other. The present review summarizes data from the most recent literature related to associations between virus infections and primary vasculitides, following the Chapel-Hill vasculitis classification.

Entities:  

Mesh:

Year:  2006        PMID: 17129519      PMCID: PMC7130152          DOI: 10.1157/13094901

Source DB:  PubMed          Journal:  Rev Clin Esp        ISSN: 0014-2565            Impact factor:   1.556


  29 in total

1.  Parvovirus B19 and Schönlein-Henoch purpura in adults.

Authors:  D Challine-Lehmann; S Mauberquez; J Pawlotsky; G Rostoker
Journal:  Nephron       Date:  1999       Impact factor: 2.847

2.  Churg-Strauss syndrome associated with HIV infection.

Authors:  Hien Nguyen; Kevin Ferentz; Alkesh Patel; Connie Le
Journal:  J Am Board Fam Pract       Date:  2005 Mar-Apr

3.  Hepatitis B virus-associated polyarteritis nodosa: clinical characteristics, outcome, and impact of treatment in 115 patients.

Authors:  Loïc Guillevin; Alfred Mahr; Patrice Callard; Pascal Godmer; Christian Pagnoux; Emmanuelle Leray; Pascal Cohen
Journal:  Medicine (Baltimore)       Date:  2005-09       Impact factor: 1.889

4.  Human parvovirus B19, varicella zoster virus, and human herpes virus 6 in temporal artery biopsy specimens of patients with giant cell arteritis: analysis with quantitative real time polymerase chain reaction.

Authors:  R Alvarez-Lafuente; B Fernández-Gutiérrez; J A Jover; E Júdez; E Loza; D Clemente; J A García-Asenjo; J R Lamas
Journal:  Ann Rheum Dis       Date:  2005-05       Impact factor: 19.103

Review 5.  Nomenclature of systemic vasculitides. Proposal of an international consensus conference.

Authors:  J C Jennette; R J Falk; K Andrassy; P A Bacon; J Churg; W L Gross; E C Hagen; G S Hoffman; G G Hunder; C G Kallenberg
Journal:  Arthritis Rheum       Date:  1994-02

6.  Adenovirus, adeno-associated virus and Kawasaki disease.

Authors:  Hiroko Shike; Chisato Shimizu; John T Kanegaye; Jennifer L Foley; David P Schnurr; Lauren J Wold; Jane C Burns
Journal:  Pediatr Infect Dis J       Date:  2005-11       Impact factor: 2.129

7.  Human serum parvovirus associated vasculitis.

Authors:  T C Li Loong; P V Coyle; M J Anderson; G E Allen; J H Connolly
Journal:  Postgrad Med J       Date:  1986-06       Impact factor: 2.401

8.  The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern.

Authors:  C Salvarani; S E Gabriel; W M O'Fallon; G G Hunder
Journal:  Ann Intern Med       Date:  1995-08-01       Impact factor: 25.391

9.  Frequency and significance of antibodies to hepatitis C virus in polyarteritis nodosa.

Authors:  C W Carson; D L Conn; A J Czaja; T L Wright; M E Brecher
Journal:  J Rheumatol       Date:  1993-02       Impact factor: 4.666

10.  Short-term corticosteroids then lamivudine and plasma exchanges to treat hepatitis B virus-related polyarteritis nodosa.

Authors:  L Guillevin; A Mahr; P Cohen; C Larroche; V Queyrel; V Loustaud-Ratti; B Imbert; P Hausfater; J Roudier; P Bielefeld; P Petitjean; D Smadja
Journal:  Arthritis Rheum       Date:  2004-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.